| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H0040 |
Assertive community treatment program, per diem |
64,377 |
7,822 |
$11.46M |
| H2015 |
Comprehensive community support services, per 15 minutes |
33,481 |
3,793 |
$6.82M |
| H0038 |
Self-help/peer services, per 15 minutes |
30,706 |
4,889 |
$4.60M |
| H2012 |
Behavioral health day treatment, per hour |
12,784 |
793 |
$2.14M |
| 90837 |
Psychotherapy, 53 minutes with patient |
28,744 |
18,888 |
$2.06M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,921 |
26,647 |
$1.48M |
| H2022 |
Community-based wrap-around services, per diem |
4,569 |
434 |
$1.17M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,114 |
7,273 |
$594K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
3,211 |
2,742 |
$573K |
| 90791 |
Psychiatric diagnostic evaluation |
3,986 |
3,462 |
$386K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,793 |
3,932 |
$316K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,075 |
2,779 |
$216K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,636 |
1,427 |
$174K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,818 |
3,487 |
$126K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,335 |
893 |
$114K |
| 96131 |
|
630 |
477 |
$73K |
| 96130 |
|
730 |
567 |
$63K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,440 |
3,209 |
$63K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,311 |
875 |
$58K |
| 80061 |
Lipid panel |
3,606 |
3,323 |
$54K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
598 |
462 |
$41K |
| 84439 |
|
3,757 |
3,453 |
$37K |
| 80053 |
Comprehensive metabolic panel |
3,330 |
3,116 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,270 |
3,064 |
$29K |
| 84481 |
|
1,393 |
1,268 |
$25K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,871 |
1,240 |
$19K |
| 96101 |
|
122 |
95 |
$17K |
| 98966 |
|
1,238 |
926 |
$15K |
| 99215 |
Prolong outpt/office vis |
321 |
215 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
4,070 |
3,739 |
$10K |
| 98968 |
|
156 |
150 |
$4K |
| 98967 |
|
162 |
160 |
$3K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
12 |
12 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
40 |
39 |
$3K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
14 |
12 |
$474.04 |
| 80050 |
General health panel |
22 |
19 |
$136.80 |